The other SubB2M test is an SPR technology (surface plasma resonance). We need the data from the SubB2M ELISA test to be certain the same performance can be achieved. No point chucking out any technologies just yet from what i understand.
- Forums
- ASX - By Stock
- IIQ
- Ann: BARD1 Collaborator Uni of QLD Announces Ovarian Cancer Data
Ann: BARD1 Collaborator Uni of QLD Announces Ovarian Cancer Data, page-15
-
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IIQ (ASX) to my watchlist
|
|||||
Last
53.0¢ |
Change
-0.025(4.50%) |
Mkt cap ! $59.10M |
Open | High | Low | Value | Volume |
55.5¢ | 55.5¢ | 53.0¢ | $41.26K | 75.94K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1231 | 53.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
56.0¢ | 31027 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1231 | 0.530 |
1 | 8000 | 0.525 |
2 | 36494 | 0.520 |
2 | 12081 | 0.510 |
2 | 15940 | 0.505 |
Price($) | Vol. | No. |
---|---|---|
0.560 | 31027 | 2 |
0.565 | 25555 | 1 |
0.580 | 10000 | 1 |
0.585 | 10000 | 1 |
0.590 | 5000 | 1 |
Last trade - 15.46pm 10/09/2024 (20 minute delay) ? |
Featured News
IIQ (ASX) Chart |